These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1635088)

  • 1. Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2.
    Murphy WJ; Longo DL
    J Natl Cancer Inst; 1992 Aug; 84(15):1195-200. PubMed ID: 1635088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo.
    Murphy WJ; Keller JR; Harrison CL; Young HA; Longo DL
    Blood; 1992 Aug; 80(3):670-7. PubMed ID: 1379086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice.
    Siefer AK; Longo DL; Harrison CL; Reynolds CW; Murphy WJ
    Blood; 1993 Oct; 82(8):2577-84. PubMed ID: 8400305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 3 enhanced interleukin 2-dependent maturation of NK progenitor cells in bone marrow from mice with severe combined immunodeficiency.
    Saikawa Y; Hasui M; Miura M; Tachinami T; Katayama K; Takano N; Miyawaki T; Koizumi S; Taniguchi N
    Cell Immunol; 1989 Nov; 124(1):38-49. PubMed ID: 2805072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
    Kalland T
    J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation.
    Murphy WJ; Bennett M; Kumar V; Longo DL
    J Immunol; 1992 May; 148(9):2953-60. PubMed ID: 1573278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo.
    Murphy WJ; Kumar V; Bennett M
    Eur J Immunol; 1990 Aug; 20(8):1729-34. PubMed ID: 2209686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine.
    Murphy WJ; Tsarfaty G; Longo DL
    Blood; 1992 Sep; 80(6):1443-7. PubMed ID: 1520871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.
    Goldman SJ
    Stem Cells; 1995 Sep; 13(5):462-71. PubMed ID: 8528095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the antitumor activity of human IL-4 by in vitro and in vivo assays.
    Wang T; Chen W
    Chin Med Sci J; 1994 Dec; 9(4):248-54. PubMed ID: 7718866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of purified recombinant human interleukin-3 on the growth of human hematopoietic progenitor cells in "long-term" bone marrow culture.
    Hangoc G; Broxmeyer HE
    Biotechnol Ther; 1989-1990; 1(1):17-29. PubMed ID: 2562641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of LAK and activated NK cells affecting hematopoiesis in mice].
    Sun K; Zhang M; Tian Z
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):405-8. PubMed ID: 11721419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
    Holmberg LA; Miller BA; Ault KA
    J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interleukin-1 (IL-1) and interleukin-2 (IL-2) on the in vivo growth and differentiation of progenitors of natural killer (NK) cells.
    Riccardi C; Rossi R; Giampietri A; Migliorati G; Biondi R
    Chemioterapia; 1984 Dec; 3(6):350-3. PubMed ID: 6335676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell subsets in the regulation of murine hematopoiesis. I. 5E6+ NK cells promote hematopoietic growth in H-2d strain mice.
    Murphy WJ; Raziuddin A; Mason L; Kumar V; Bennett M; Longo DL
    J Immunol; 1995 Sep; 155(6):2911-7. PubMed ID: 7673708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
    J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood.
    Sun R; Wei H; Zhang J; Tian Z
    Haematologica; 2003 May; 88(5):561-9. PubMed ID: 12745276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro generation of natural killer cells from SJL/J bone marrow precursors.
    D'Adamio L; Cannarile L; Migliorati G; Riccardi C
    J Biol Regul Homeost Agents; 1988; 2(2):71-6. PubMed ID: 3263749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo augmentation of natural killer activity by combined treatment with recombinant gamma interferon and interleukin-2.
    Shalaby MR; Svedersky LP; McKay PA; Finkle BS; Palladino MA
    J Interferon Res; 1985; 5(4):571-81. PubMed ID: 3936881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.